Skip to Main Content

Paper Details

Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System.
Future Oncol
2
2022
Author NameAffiliation
Sunita GhoshUniversity of Alberta & Cross Cancer Institute
  • 1 - 1

Datasets

Release 1.2